Status: 03.05.2021 7:21 p.m.
It was only in April that the Danish government stopped vaccinating with AstraZeneca, and now the US manufacturer Johnson & Johnson’s vaccine is no longer used. Again, this is due to reports of blood clots.
Denmark has removed Johnson & Johnson’s corona virus vaccine from its vaccination program with information about rare blood clots. He concluded that “the benefits of using the Govit-19 vaccine from Johnson & Johnson are far greater than the risk of adverse effects,” according to the Danish Health Commission.
Danes also discontinued the Astrogeneca vaccine
It was one of the first countries in the world to receive a vaccine from an American pharmaceutical company. In April, the Danish government became the first country in Europe to stop vaccinating with AstraZeneca for the same reason.
Despite reports of blood clots, the EU Pharmaceuticals (EMA) decided in April to stick to a positive risk assessment of the corona vaccine from Johnson & Johnson.
The EMA explained that there is a “potential link” between vaccination and occasional blood clots. The benefits of the vaccine outweigh the risks.
U.S. officials recently gave the green light to Johnson & Johnson’s vaccine after a temporary suspension.
“Satisfactory” vaccine campaign
Helen Probst, the company’s deputy director general, said vaccination appointments would be postponed for up to four weeks because the vaccine is no longer used in Denmark.
Corona infection is currently “under control” in Denmark. In addition, “the vaccine campaign continues satisfactorily with other available vaccines”.
It is unclear what will happen to the cans already delivered. Meanwhile, a debate has erupted in the country over whether Johnson & Johnson and Astrogeneca should be vaccinated on a voluntary basis.